Etoposide
- Product NDC
- 0378-3266
- 11-digit product format
- 003783266
- Labeler code
- 0378
- Product ID
- 0378-3266_a591eea6-af04-4207-b0f7-61fbada4719c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- etoposide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA075635
- Marketing category
- ANDA
- Marketing start
- 2001-10-22
- Substance
- ETOPOSIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Etoposide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETOPOSIDE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6PLQ3CP4P3 |
| Rxcui | 197687 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0378-3266-94 | Etoposide | 20 in 1 CARTON | CAPSULE | 20 | | 9 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0378-3266 | ETOPOSIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 9 | Current NDC, Legacy NDC, 1 package rows | 20181019_508a418e-985f-4208-9324-2230655bb5c2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-3266-94 | 00378326694 | 20 CAPSULE in 1 CARTON (0378-3266-94) | 20 capsule | 2001-10-22 | 0000-00-00 | No | No | Current |